Recevez les dernières nouvelles sur l'action OmniAb avec des mises à jour sur les tendances du marché, les données financières et les analyses de Benzinga. Restez informé des performances de OABI

Dernières nouvelles pour

OMNIAB INC

OmniAb

OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

OmniAb Inc

News

IPOs

Press Releases

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

OmniAb Introduces the xPloration® Partner Access Program

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

Small Cap

Opinion

AI Is Quietly Reinventing Healthcare--And Real Deployments Are Now Underway

OmniAb to Report Second Quarter 2025 Financial Results on August 6

OmniAb Reports Second Quarter 2025 Financial Results and Business Highlights

OmniAb Announces $30 Million Private Placement

OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

OmniAb to Report Third Quarter 2025 Financial Results on November 4

OmniAb to Participate in Three Investor Conferences in November

AVAI

OABI

RXRX

TVGN

VACH

Atlantic International Corp. - Common Stock

Atlantic International

Applied DNA Sciences, Inc. - Common Stock

Applied DNA Sciences

Bionano Genomics

CDT Equity

Codexis

Champions Oncology

Cytek Biosciences

CryoPort

Harvard Bioscience

MindWalk Holdings

Standard BioTools

Lifecore Biomedical

Mesa Laboratories

Maravai LifeSciences Holdings, Inc. - Class A common stock

Maravai LifeSciences

MaxCyte

Niagen Bioscience

Nautilus Biotechnology, Inc. - Common Stock

Nautilus Biotechnology

Inotiv

Pacific Biosciences of California, Inc. - Common Stock

Pacific Biosciences

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si

Quanterix

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems

Seer

Alpha Teknova

RBC Capital

Benchmark

HC Wainwright & Co.

Truist Securities

Craig-Hallum

Comments

OmniAb Actualités boursières

Actualités

Dernières nouvelles pour

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL